- Language: English
- Published: March 2008
Infections - Bacterial Infections Drug Pipeline Report
- Published: June 2007
- 22 pages
- Life Science Analytics
Life Science Analytics, "Infections - Bacterial Infections Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of bacterial infections drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
- Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage. SHOW LESS READ MORE >
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Bacterial Infections Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Top Companies in late stage Bacterial Infections Projects
--Asubio Pharma Co., Ltd.
--Asahi Kasei Corporation
--Hi-Tech Pharmacal Co Inc
--DAIICHI SANKYO COMPANY, LIMITED
--Meiji Seika Kaisha, Ltd.
--Kyoto Pharmaceutical Industries
--Nippon Shinyaku Co., Ltd.
--Ranbaxy Laboratories Ltd.
--Roche Holdings Ltd
--Rib-X Pharmaceuticals, Inc.
--Teva Pharmaceutical Industries Ltd
--Taisho Pharmaceutical Co., Ltd.
--TOYAMA CHEMICAL CO.,LTD.
--Top Companies in early stage Bacterial Infections Projects
--Affinium Pharmaceuticals, Inc.
--ADVENTRX Pharmaceuticals Inc
--Amura Holdings Ltd.
--Basilea Pharmaceutica AG
--DAIICHI SANKYO COMPANY, LIMITED
--Forest Laboratories Inc
--Dainippon Sumitomo Pharma Co., Ltd.
--Inimex Pharmaceuticals Inc.
--Paratek Pharmaceuticals, Inc
--Vertex Pharmaceuticals Inc
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Approved Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View
|Electronic (PDF)||The report will be emailed to you. The report is sent in PDF format.|
|Hard Copy||A printed copy of the report will be shipped to you.|